University of Oxford

Older adult receiving vaccine
#Dementia #Immunology / Virology & Vaccines #Neurodegenerative disorders #Neuroscience #Shingles #University of Oxford

New shingles vaccine found to reduce risk of dementia

New evidence indicates that a new shingles vaccine is more protective against dementia compared to the previous shingles vaccine, which was also reported to reduce dementia rates. It is also more protective than vaccines against other infections. A study of more… Read More

#News

MRI of the brain
#Africa #Collaboration #epilepsy #LMICs #University of Oxford

Oxford centre to address global epilepsy challenges

The University of Oxford is launching The Centre for Global Epilepsy to address the global burden of epilepsy, particularly in lower-income countries. Based at Wolfson College, Oxford, the Centre for Global Epilepsy will collaborate with key research institutions and epilepsy clinics worldwide, linking expertise from high-income… Read More

#News

#Genetics / genomics #Neurodevelopmental disorders #University of Oxford #Whole genome sequencing

Researchers discover genetic cause of neurodevelopment disorders

A global collaboration led by scientists at the University of Oxford has discovered that genetic variants in a specific gene cause a rare neurodevelopmental disorder (NDD). NDD is a collective term for severe impairments in how the brain functions that impact learning, behaviour, speech, and movement. Read More

#News

Colourised scanning electron micrograph of Marburg virus particles
#Clinical trial #Immunology / Virology & Vaccines #University of Oxford #Vaccine candidate

First-in-human vaccine trial for deadly Marburg virus

Scientists at the University of Oxford in the UK have launched a new clinical trial to test a vaccine to protect against “devastating” Marburg virus. This is the first-in-human trial of the ChAdOx1 Marburg vaccine, which has been developed and manufactured by researchers at the University… Read More

#News #Trending News

Gene sequence
#Antibiotics #Genetics / genomics #Sepsis #University of Oxford #Wellcome Sanger Institute

New study uses genetics to identify best sepsis treatment

New research has uncovered how different people respond to sepsis based on their genetics, which could lead to the development of targeted therapies. The team from the Wellcome Sanger Institute, the University of Oxford, and collaborators built on their previous work that identified different subgroups of… Read More

#Editor's Choice #News

Vaccine
#Clinical trial #Immunology / Virology & Vaccines #Interview #University of Oxford #Vaccines

Vaccines and various response rates

DDW Editor Reece Armstrong speaks to Dr Katrina Pollock from the Oxford Vaccine Group at the University of Oxford. Dr Pollock is the Chief Investigator of the LEGACY03 clinical trial, a study aiming to investigate lymph nodes and vaccination responses across age groups. RA: Could you tell us about the… Read More

#Exclusive Content

Diversity
#Clinical trial design #Clinical trials #Diversity #University of Oxford

Deterrents to trial participation among ethnic minorities revealed

Safety and health concerns, time investment, and lack of support are the top three barriers to participation in clinical studies among ethnic minorities, according to a new report. The study examined the motivators and deterrents of clinical trial participation among ethnic minorities and outlined strategies sponsors can utilise… Read More

#News

#Allogene Therapeutics #allogeneic cell therapies #Biologics #Biotech #Cancer Research Horizons #Cancer vaccine #CAR-T #Cell therapy #Clinical trials #Drug discovery #Financing #Funding #LifeArc #Oncology #Rare disease #Research and development #Seed funding #Start-ups #University of Dundee #University of Oxford

New DDW Highlights episode: 8 May 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The ongoing innovation and development in the drug discovery sector relies on a number… Read More

#News

#Allogene Therapeutics #allogeneic cell therapies #Biologics #Biotech #Cancer Research Horizons #Cancer vaccine #CAR-T #Cell therapy #Clinical trials #Drug discovery #Financing #Funding #LifeArc #Oncology #Rare disease #Research and development #Seed funding #Start-ups #University of Dundee #University of Oxford

This week in drug discovery (29 April – 3 May) 

News round-up for 29 April – 3 May by DDW Multimedia Editor Megan Thomas. The ongoing innovation and development in the drug discovery sector relies on a number of moving parts, one of which is financial support and backing. Whether it is successful seed funding or dedicated investment,… Read More

#News

Covid-19
#Covid-19 #Immunity #Immunology / Virology & Vaccines #University of Oxford

Study proves value of infection studies in developing new vaccines

A study led by the University of Oxford has successfully investigated human immunity against Covid-19 in people who already have antibodies, with the aim of advancing future vaccines and treatments. The results suggest that previous infection, together with vaccination, offers strong protection against the original Covid-19… Read More

#News

GBP pound sterling funding
#Biotech #Cancer Research Horizons #Cancer vaccine #Oncology #Start-ups #University of Oxford

Cancer vaccine developer secures £12.8m

Oxford University spin-out Infinitopes Precision Immunomics has completed a £12.8 ($16) million seed funding round led by Octopus Ventures. The round was heavily oversubscribed, also drawing in funds from Cancer Research Horizons, Cancer Research Institute, CRIS Cancer Foundation, Kindred Capital, Manta Ray, Martlet Capital, Meltwind Advisory, Saras Capital, Wilbe Capital,… Read More

#Business & Investment #News #Start-up Zone

Scan of the lungs showing tuberculosis
#Immunology / Virology & Vaccines #TB vaccine #Tuberculosis #University of Oxford

Human infection model drives forward TB vaccine development

For the first time, a controlled human infection model for tuberculosis (TB) has been developed and could help with the future development of TB vaccines. Researchers from the University of Oxford developed the infection model, which replicates how TB enters the body by infecting people… Read More

#News

#Artificial intelligence (AI) #Cancer Research UK #Oncology #Prostate cancer #University of East Anglia #University of Oxford

AI reveals prostate cancer is not just one disease

Research published in Cell Genomics has shown that prostate cancer includes two different subtypes of the disease, also known as evotypes. This discovery was made by using artificial intelligence (AI) to help unlock new discoveries about the evolution of prostate cancer and could lead to the… Read More

#Cancer Research #News #Trending News

Older adult receiving vaccine
#Covid-19 #Immunity #Immunology / Virology & Vaccines #Influenza #University of Oxford

Collaborative study to improve flu and Covid-19 vaccine design

With funding from MRC/UKRI, the University of Oxford has assembled a team of scientists, radiologists and clinicians to research and understand the cause and effect of varying responses to vaccination. The results will assist researchers in designing vaccines which will offer greater protection to the most… Read More

#News

Doctor looks at x-ray of the lungs
#Clinical trial #Drug delivery #Immunology / Virology & Vaccines #TB #TB vaccine #University of Oxford

Clinical trial will test novel inhaled TB vaccine

A new study will compare whether giving tuberculosis vaccine by inhalation is better at protecting against tuberculosis (TB) than injection into the skin. The Jenner Institute at the University of Oxford is conducting the study using Bacille Calmette-Guérin (BCG), the current licensed vaccine against TB. Read More

#News

Patient receiving vaccine
#CEPI #Immunology / Virology & Vaccines #Nipah Virus #Pandemic prevention #University of Oxford

In-human trial begins for first potential Nipah virus vaccine

The first clinical trial participants have received doses of the ChAdOx1 NipahB vaccine at the University of Oxford. Nipah virus is mostly found in South-East Asia that can be fatal in up to 75% of cases. Despite the first outbreaks occurring 25 years ago in… Read More

#News